Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Avenir Complete Post-Market Clinical Follow-Up Study

NCT: NCT04731077 · ACTIVE_NOT_RECRUITING

NCT IDNCT04731077
StatusACTIVE_NOT_RECRUITING
Start Date2021-09-27
Completion2036-06-01
SponsorZimmer Biomet (INDUSTRY)
First posted
Last updated

Brief Summary

The main objectives of this study are to confirm the long-term safety, performance and clinical benefits the Avenir Complete femoral stem and its instrumentation when used in primary total, hemi, and revision hip arthroplasty.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑